The recent run of good fortune for vaccine maker Novavax (NASDAQ:NVAX continues. Following the major licensing deal with ...
(Reuters) -Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors ...
Novavax (NVAX) stock surged after reaching a licensing agreement with Sanofi (SNY) for its COVID-19 vaccine and Matrix-M adjuvant. Read more here.
Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
Shares of vaccine stocks Moderna ( MRNA 1.58%), Novavax ( NVAX 2.31%), and BioNTech SE ( BNTX -2.07%) rallied this week, ...
Shah Capital, a top shareholder of Novavax (NASDAQ:NVAX), has withdrawn its proxy campaign against the company days after the COVID-19 vaccine maker struck a licensing agreement with French pharma ...
The Biden administration's new tariffs on Chinese electric vehicles and other strategic sectors aim to protect the future of ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
In the stock market, a back-from-the-dead story is equally appealing. Stocks that have been left for dead, or at least seen ...
The S&P 500 is on the longest streak since February, partly buoyed by stocks with analyst upgrades. The Dow Jones Industrial ...
Detailed price information for Catalyst Pharm Inc (CPRX-Q) from The Globe and Mail including charting and trades.
The Coral Bay Club, a member-owned club that dates to 1958, demolished its longtime home and is building a new facility. The ...